NASDAQ: CALCCalcimedica Inc Stock Ownership - Who owns Calcimedica?
Insider buying vs selling
Have Calcimedica Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Sudarshan Hebbar | Chief Medical Officer | 2026-06-25 | 124,486 | $0.80 | $99.96kBuy |
| A. Rachel Leheny | CHIEF EXECUTIVE OFFICER | 2026-06-25 | 186,729 | $0.80 | $149.94kBuy |
| Fred A. Middleton | Director | 2026-06-25 | 248,972 | $0.80 | $199.92kBuy |
| Eric W. Roberts | CHIEF BUSINESS OFFICER | 2026-06-25 | 186,729 | $0.80 | $149.94kBuy |
| Robert N. Wilson | Director | 2026-06-25 | 1,182,621 | $0.80 | $949.64kBuy |
CALC insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CALC insiders and whales buy or sell their stock.
CALC Shareholders
What type of owners hold Calcimedica Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| James E. Flynn | 77.35% | 5,281,713 | $6.36M | Insider |
| Alafi Capital Co LLC | 74.87% | 5,112,345 | $6.16M | Insider |
| Orbimed Advisors LLC | 60.97% | 4,163,347 | $5.02M | Insider |
| Fred A. Middleton | 49.85% | 3,404,222 | $4.10M | Insider |
| Sanderling Venture Partners VI Co Investment Fund LP | 35.25% | 2,407,172 | $2.90M | Insider |
| Sanderling Venture Partners VI LP | 33.97% | 2,319,428 | $2.79M | Insider |
| Evgeny Zaytsev | 30.95% | 2,113,513 | $2.55M | Insider |
| Clarus Lifesciences III LP | 28.27% | 1,930,395 | $2.33M | Insider |
| Christy L. Shaffer | 23.53% | 1,606,669 | $1.94M | Insider |
| Robert N. Wilson | 23.50% | 1,604,650 | $1.93M | Insider |
CALC vs Biotech Stocks
Calcimedica Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.